Search

everythinglearnresearchcommunity

for

Search:↓

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

FUE and FUT hair transplants have similar success rates, with FUE slightly better.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

High DKK1 levels predict worse survival in head and neck cancer.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Vesicles from irradiated mouse cheek skin help cells survive radiation.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

PRP therapy may effectively treat hair loss, but more research needed.

The upper half of a human hair follicle can grow a new hair in a mouse, but success is rare.

Flap surgery is effective for treating male baldness, offering immediate results with dense hair growth.

FUE megasession effectively treats severe hair loss with natural-looking results in one operation.

PRP did not significantly improve hair restoration results but improved scar tissue quality.

PRP improves FUE hair transplant results.

FUT-MD hair transplants have higher follicle survival rates than FUE transplants.

Hair transplantation has improved with techniques that increase graft survival and patient satisfaction for more natural results.

New instruments were introduced to make hair transplantation surgery more precise and improve graft survival.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Melanoma survival rates vary by state and are better where incomes are higher, more people have health insurance and education, and there are more dermatologists.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.